Please assess the completion status of the following clinical trial:

Trial Title: Energy Consumption and Cardiorespiratory Load During Walking With and Without Robot-Assistance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Stroke patients with a lower limb motor impairment~* Time since stroke \< 1 year~* ≥ 18 years~* \< 193 cm~* \< 135kg~* Able to walk overground (body-weight support allowed if necessary) for at least 10 minutes at a comfortable walking speed~Exclusion Criteria:~* Contra-indications for exercise testing according to the American College of Sports Medicine~* Musculoskeletal problems (other than stroke) affecting the ability to walk~* Concurrent pulmonary diseases~* Concurrent neurological diseases~* Communicative and/or cognitive problems affecting the ability to comprehend or follow instructions~* Other problems that affect the execution of the interventions, e.g. severe spasticity, contractures or dermatologic contraindications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lokomat - Treadmill - Overground (Type: EXPERIMENTAL): Walking order: lokomat walking, treadmill walking, overground walking
- Lokomat - Overground - Treadmill (Type: EXPERIMENTAL): Walking order: lokomat walking, overground walking, treadmill walking
- Treadmill - Lokomat - Overground (Type: EXPERIMENTAL): Walking order: treadmill walking, lokomat walking, overground walking
- Treadmill - Overground - Lokomat (Type: EXPERIMENTAL): Walking order: treadmill walking, overground walking, lokomat walking
- Overground - Lokomat - Treadmill (Type: EXPERIMENTAL): Walking order: overground walking, lokomat walking, treadmill walking
- Overground - Treadmill - Lokomat (Type: EXPERIMENTAL): Walking order: overground walking, treadmill walking, lokomat walking

Based on this trial design, predict the completion outcome and termination type (if applicable).